278.17
-0.38(-0.14%)
Currency In USD
Address
100 Nagog Park
Acton, MA 01720
United States of America
Phone
978 600 7000
Website
Sector
Healthcare
Industry
Medical - Devices
Employees
3900
First IPO Date
May 15, 2007
| Name | Title | Pay | Year Born |
| Ashley A. McEvoy | Chief Executive Officer, President & Director | 2.88M | 1971 |
| Flavia H. Pease | Executive VP & CFO | 53,083 | 1973 |
| John Wodick Kapples | Senior VP & General Counsel | 1.06M | 1960 |
| Eric Benjamin | Executive VP & COO | 1.24M | 1983 |
| Amit Guliani | Chief Technology Officer | 0 | N/A |
| Andrew Isaacson | Senior VP of Strategy & Corporate Development | 0 | N/A |
| Philip Hildale | Senior Vice President of Sales & Customer Care | 0 | N/A |
| Angela Geryak Wiczek | Senior Director of Corporate Communications | 0 | N/A |
| Clare Trachtman | Vice President of Investor Relations | 0 | N/A |
| Laetitia Cousin | Senior VP of Regulatory Affairs, Quality Assurance & Compliance | 0 | 1976 |
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.